MRI Scans for Chronic Lung Disease
Trial Summary
What is the purpose of this trial?
Male and female subjects age 18-85 with lung disease will inhale 5ml/kg (patient body weight) hyperpolarized helium and will be scanned using MRI at 3 Tesla, to evaluate the Apparent Diffusion Coefficient (ADC), ventilation defect volume and percent ventilation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment MRI for chronic lung disease?
MRI for lung imaging has improved significantly, offering both structural and functional assessments without radiation exposure, making it useful for conditions like pulmonary vascular disease and airway diseases. Although its application for chronic lung diseases like COPD and asthma is still under investigation, MRI's ability to provide comprehensive imaging is promising.12345
Is MRI safe for use in humans, especially for lung conditions?
MRI is generally considered safe for humans as it does not involve exposure to ionizing radiation, making it a preferred option for children and young adults who need repeated imaging. It is used for various lung conditions and has been shown to replace many CT scans without losing diagnostic quality.24567
How is MRI used as a treatment for chronic lung disease different from other treatments?
MRI (Magnetic Resonance Imaging) is unique for chronic lung disease as it provides detailed images of the lungs without using radiation, unlike CT scans. It can help differentiate between various lung conditions and is particularly useful in cases where radiation exposure should be minimized, such as in children or for repeated imaging.238910
Research Team
Grace E Parraga, PhD
Principal Investigator
Robarts Research Institute, The University of Western Ontario
Eligibility Criteria
This trial is for men and women aged 18-75 with various lung diseases who can hold their breath for 16 seconds, have an FEV1 >25% predicted, and a Forced Vital Capacity (FVC) >25% predicted. Participants must understand the study and consent to join. Exclusions include having metal implants or conditions that prevent MRI use like severe claustrophobia.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo medical history review, vital signs check, and full pulmonary function tests
MRI Assessment
Participants inhale hyperpolarized helium and undergo MRI scans to evaluate lung function and microstructure
Follow-up
Participants are monitored for changes in lung function and microstructure over time
Treatment Details
Interventions
- MRI (Imaging)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Western University, Canada
Lead Sponsor